REFER TO LOCAL TRUST PROTOCOL FOR CONCENTRATED POTASSIUM SOLUTIONS
Addiphos injection (potassium supplementation)
Formulary
30 mmol K+ in 20mL
20mL also contains:
40mmol Phosphate
30mmol Sodium
REFER TO LOCAL TRUST PROTOCOL FOR CONCENTRATED POTASSIUM SOLUTIONS
Cardioplegia infusion
Formulary
16 mmol K+ in 20mL
REFER TO LOCAL TRUST PROTOCOL FOR CONCENTRATED POTASSIUM SOLUTIONS
For myocardial protection during cardiac surgery
Potassium acetate injection
Formulary
10 mmol K+ in 10mL
REFER TO LOCAL TRUST PROTOCOL FOR CONCENTRATED POTASSIUM SOLUTIONS
Potassium acid phosphate injection 13.6%
Formulary
10 mmol K+ in 10mL
REFER TO LOCAL TRUST PROTOCOL FOR CONCENTRATED POTASSIUM SOLUTIONS
Potassium chloride 1.5% in sodium chloride 0.9% infusion minibag
Unlicensed
20 mmol K+ in 100mL
REFER TO LOCAL TRUST PROTOCOL FOR CONCENTRATED POTASSIUM SOLUTIONS
Potassium chloride 3% in sodium chloride 0.9% infusion minibag
Unlicensed
40 mmol K+ in 100mL
REFER TO LOCAL TRUST PROTOCOL FOR CONCENTRATED POTASSIUM SOLUTIONS
Potassium chloride 3% in sodium chloride 0.9% prefilled syringe 50mL
Unlicensed
20 mmol K+ in 50mL
REFER TO LOCAL TRUST PROTOCOL FOR CONCENTRATED POTASSIUM SOLUTIONS
Potassium chloride 7.5% in sodium chloride 0.9% prefilled syringe 50mL
Unlicensed
50 mmol K+ in 50mL
REFER TO LOCAL TRUST PROTOCOL FOR CONCENTRATED POTASSIUM SOLUTIONS
09.02.02.01
Bicarbonate and lactate
Sodium bicarbonate 1.26% intravenous infusion
Formulary
Sodium Bicarbonate 1.4% intravenous infusion
Formulary
Sodium Bicarbonate 2.74% intravenous infusion
Formulary
Sodium Bicarbonate 8.4% intravenous infusion
Formulary
09.02.02.01
Water
Water for Injections
Formulary
....
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to SPCs
Scottish Medicines Consortium
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
CCG
Traffic Light Status Information
Status
Description
Specialist or hospital prescribing only.
The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital.
In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.
Treatment can be initiated in primary care after a recommendation from an appropriate specialist
Specialist initiation followed by maintenance prescribing in primary care
Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation
Restricted
Restricted to use in Critical Care, and intraoperative use in the following procedures:
30 mmol K+ in 20mL
Unlicensed
50 mmol K+ in 50mL
